These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6587517)

  • 1. [Cross reactions of HLA A and B antigens in 63 patients with rheumatoid arthritis].
    Dreyfus P; Geay D; Cambon H; Daupleix D
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):197-202. PubMed ID: 6587517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
    Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
    Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.
    Dequeker J; Van Wanghe P; Verdickt W
    J Rheumatol; 1984 Jun; 11(3):282-6. PubMed ID: 6376799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histocompatibility antigens (A, B, C, and DR) in Arabs with rheumatoid arthritis.
    Sattar MA; al-Saffar M; Guindi RT; Sugathan TN; White AG; Behbehani K
    Dis Markers; 1990; 8(1):11-5. PubMed ID: 2311344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
    Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
    J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA and rheumatoid arthritis: susceptibility or severity?
    Jaraquemada D; Ollier W; Awad J; Young A; Festenstein H
    Dis Markers; 1986 Jun; 4(1-2):43-53. PubMed ID: 3482987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to rheumatoid arthritis associated nuclear antigen (RANA) in familial rheumatoid arthritis.
    Bell DA; Alspaugh MA
    J Rheumatol; 1984 Jun; 11(3):277-81. PubMed ID: 6610751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis.
    Sweatman MC; Markwick JR; Charles PJ; Jones SE; Prior JM; Maini RN; Turner-Warwick ME
    Dis Markers; 1986 Jun; 4(1-2):19-26. PubMed ID: 3133152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA studies in familial and sporadic rheumatoid arthritis.
    Khan MA; Khan MK
    Dis Markers; 1986 Jun; 4(1-2):67-76. PubMed ID: 3482988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seronegative rheumatoid arthritis: a clinical study with HLA typing.
    Kaarela K; Alekberova Z; Lehtinen K; Puolakka K; Koskimies S; Nassonova V; Pospelov L
    J Rheumatol; 1990 Sep; 17(9):1125-9. PubMed ID: 2290153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA alleles and clinical features in patients with synovitis of recent onset.
    El-Gabalawy HS; Goldbach-Mansky R; Smith D; Arayssi T; Bale S; Gulko P; Yarboro C; Wilder RL; Klippel JH; Schumacher HR
    Arthritis Rheum; 1999 Aug; 42(8):1696-705. PubMed ID: 10446870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis.
    Gran JT; Husby G; Thorsby E
    J Rheumatol; 1984 Apr; 11(2):136-40. PubMed ID: 6610047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4.
    Scherak O; Smolen JS; Mayr WR
    J Rheumatol; 1980; 7(1):9-12. PubMed ID: 6965505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.
    Darke C; Wagner MM; Nuki G; Dyer PA
    Br J Dis Chest; 1983 Jul; 77(3):235-42. PubMed ID: 6577907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.